- Home
- CALC vs HYFM Comparison
CALC vs HYFM Comparison
Compare CALC & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- HYFM
- Stock Information
- Founded
- CALC 2011
- HYFM 1977
- Country
- CALC United States
- HYFM United States
- Employees
- CALC N/A
- HYFM N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- HYFM Industrial Machinery/Components
- Sector
- CALC Health Care
- HYFM Industrials
- Exchange
- CALC Nasdaq
- HYFM Nasdaq
- Market Cap
- CALC 20.9M
- HYFM 22.8M
- IPO Year
- CALC N/A
- HYFM 2020
- Fundamental
- Price
- CALC $1.91
- HYFM $3.11
- Analyst Decision
- CALC Strong Buy
- HYFM Hold
- Analyst Count
- CALC 3
- HYFM 2
- Target Price
- CALC $16.33
- HYFM $7.00
- AVG Volume (30 Days)
- CALC 33.2K
- HYFM 43.3K
- Earning Date
- CALC 05-14-2025
- HYFM 05-13-2025
- Dividend Yield
- CALC N/A
- HYFM N/A
- EPS Growth
- CALC N/A
- HYFM N/A
- EPS
- CALC N/A
- HYFM N/A
- Revenue
- CALC N/A
- HYFM $176,650,000.00
- Revenue This Year
- CALC N/A
- HYFM $5.45
- Revenue Next Year
- CALC N/A
- HYFM $5.33
- P/E Ratio
- CALC N/A
- HYFM N/A
- Revenue Growth
- CALC N/A
- HYFM N/A
- 52 Week Low
- CALC $1.43
- HYFM $1.50
- 52 Week High
- CALC $6.02
- HYFM $10.00
- Technical
- Relative Strength Index (RSI)
- CALC 56.52
- HYFM 49.34
- Support Level
- CALC $1.86
- HYFM $2.28
- Resistance Level
- CALC $2.04
- HYFM $4.61
- Average True Range (ATR)
- CALC 0.14
- HYFM 0.46
- MACD
- CALC 0.05
- HYFM 0.05
- Stochastic Oscillator
- CALC 64.79
- HYFM 34.19
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.